Format

Send to:

Choose Destination
See comment in PubMed Commons below
Health Aff (Millwood). 2011 Jun;30(6):1073-9. doi: 10.1377/hlthaff.2011.0303.

The challenges of developing new tuberculosis vaccines.

Author information

  • 1Aeras, Rockville, Maryland, USA.lbarker@aeras.org

Abstract

The World Health Organization estimates that tuberculosis is causing nearly two million deaths annually, mostly in developing countries. Widespread administration of the current tuberculosis vaccine to newborns is not a reliable route for preventing the disease in adults, the population that drives the epidemic. Several new vaccine candidates are in development, and a few have entered clinical trials. However, the field faces formidable scientific and policy challenges. A collaborative approach to solving scientific, policy, and resource obstacles--as well as new partnerships among emerging economies and vaccine development organizations--will be critical to developing a new tuberculosis vaccine that could achieve its public health potential to save lives and reduce the burden of disease.

PMID:
21653959
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk